SOCS3 is an endogenous inhibitor of pathologic angiogenesisSTAHL, Andreas; JOYAL, Jean-Sebastian; DENNISON, Roberta J et al.Blood. 2012, Vol 120, Num 14, pp 2925-2929, issn 0006-4971, 5 p.Article

Sense of coherence and health behaviour in adolescenceMATTILA, M.-L; RAUTAVA, P; HONKINEN, P.-L et al.Acta paediatrica (Oslo). 2011, Vol 100, Num 12, pp 1590-1595, issn 0803-5253, 6 p.Article

Serum amyloid A overrides T_reg anergy via monocyte-dependent and T_reg-intrinsic, SOCS3-associated pathwaysNGUYEN, Khoa D; MACAUBAS, Claudia; NADEAU, Kari C et al.Blood. 2011, Vol 117, Num 14, pp 3793-3798, issn 0006-4971, 6 p.Article

SOCS3 promotes interleukin-17 expression of human T cellsKLEINSTEUBER, Katja; HEESCH, Kerrin; SCHATTLING, Stefanie et al.Blood. 2012, Vol 120, Num 22, pp 4374-4382, issn 0006-4971, 9 p.Article

Suppressors of Cytokine Signaling Abrogate Diabetic NephropathyORTIZ-MUNOZ, Guadalupe; LOPEZ-PARRA, Virginia; EGIDO, Jesus et al.Journal of the American Society of Nephrology. 2010, Vol 21, Num 5, pp 763-772, issn 1046-6673, 10 p.Article

Putting out the fire : coordinated suppression of the innate and adaptive immune systems by SOCS 1 and SOCS3 proteinsDIMITRIOU, Ioannis D; CLEMENZA, Liliana; SCOTTER, Andrew J et al.Immunological reviews. 2008, Vol 224, pp 265-283, issn 0105-2896, 19 p.Article

SOCS3 regulates graft-versus-host diseaseHILL, Geoffrey R; KUNS, Rachel D; ROBERTS, Andrew W et al.Blood. 2010, Vol 116, Num 2, pp 287-296, issn 0006-4971, 10 p.Article

Role of neonatal hyperleptinaemia on serum adiponectin and suppressor of cytokine signalling-3 expression in young ratsFONSECA PASSOS, Magna Cottini; PEREIRA TOSTE, Fabiane; POTENTE DUTRA, Sheila Cristina et al.British journal of nutrition. 2009, Vol 101, Num 2, pp 250-256, issn 0007-1145, 7 p.Article

Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cellsTAKAHASHI, Yuki; KANEDA, Haruka; TAKASUKA, Nana et al.Cancer science. 2008, Vol 99, Num 8, pp 1650-1655, issn 1347-9032, 6 p.Article

SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer GrowthBERGER, Hélène; VEGRAN, Frédérique; CHEVRIAUX, Angélique et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3578-3590, issn 0008-5472, 13 p.Article

Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-αTOMITA, Shintaro; ISHIBASHI, Kei; YAMAGUCHI, Osamu et al.Cancer science. 2011, Vol 102, Num 1, pp 57-63, issn 1347-9032, 7 p.Article

Antigen Presentation by Dendritic Cells in Tumors Is Disrupted by Altered Metabolism that Involves Pyruvate Kinase M2 and Its Interaction with SOCS3ZHUOHAN ZHANG; QIAOFEI LIU; YUAN ZHANG et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 1, pp 89-98, issn 0008-5472, 10 p.Article

Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammationHASHIMOTO, Masayuki; AYADA, Toranoshin; KINJYO, Ichiko et al.Cancer science. 2009, Vol 100, Num 4, pp 730-736, issn 1347-9032, 7 p.Article

The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD miceHULTCRANTZ, M; JACOBSON, S; HILL, N. J et al.Diabetologia (Berlin). 2009, Vol 52, Num 2, pp 299-305, issn 0012-186X, 7 p.Article

The molecular physiology of CRAC channelsPRAKRIYA, Murali.Immunological reviews. 2009, Vol 231, pp 88-98, issn 0105-2896, 11 p.Article

Orail-STIM1 formed store-operated Ca²⁺ channels (SOCs) as the molecular components needed for Pb²⁺ entry in living cellsCHANG, Yu-Fen; TENG, Hsiao-Chuan; CHENG, Sha-Yen et al.Toxicology and applied pharmacology. 2008, Vol 227, Num 3, pp 430-439, issn 0041-008X, 10 p.Article

SOCS in situ expression in tuberculous lymphadenitis in an endemic areaNICOL, A. F; NUOVO, G. J; COELHO, J. M. C et al.Experimental and molecular pathology. 2008, Vol 84, Num 3, pp 240-244, issn 0014-4800, 5 p.Article

Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic CellsBANGXING HONG; WENHONG REN; SONG, Xiao-Tong et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 20, pp 8076-8084, issn 0008-5472, 9 p.Article

Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entitiesMOTTOK, Anja; RENNE, Christoph; SEIFERT, Marc et al.Blood. 2009, Vol 114, Num 20, pp 4503-4506, issn 0006-4971, 4 p.Article

SOCS3 Negatively Regulates the gp130-STAT3 Pathway in Mouse Skin Wound HealingZHU, Bing-Mei; ISHIDA, Yuko; ROBINSON, Gertraud W et al.Journal of investigative dermatology. 2008, Vol 128, Num 7, pp 1821-1829, issn 0022-202X, 9 p.Article

Role of SOCS1 in tumor progression and therapeutic applicationJING ZHANG; HUI LI; YU, Jin-Pu et al.International journal of cancer (Print). 2012, Vol 130, Num 9, pp 1971-1980, issn 0020-7136, 10 p.Article

Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformationCOOPER, John C; MINGJIAN SHI; CHUEH, Fu-Yu et al.International journal of oncology. 2010, Vol 36, Num 5, pp 1201-1208, issn 1019-6439, 8 p.Article

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disordersFOUROUCLAS, Nasios; JUAN LI; GREEN, Anthony R et al.Haematologica (Roma). 2008, Vol 93, Num 11, pp 1635-1644, issn 0390-6078, 10 p.Article

Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patientsJACOBSEN, M; REPSILBER, D; KLEINSTEUBER, K et al.Clinical microbiology and infection. 2011, Vol 17, Num 9, pp 1323-1331, issn 1198-743X, 9 p.Article

Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylationHONG-BROWN, Ly Q; BROWN, C. Randell; COONEY, Robert N et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 1, pp E63-E72, issn 0193-1849Article